Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Turkish Journal of Medical Sciences|October 30, 2024
Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosisHasan Satiş, Abdulsamet Erden, Emre Bilgin, et al.
International Journal of Rheumatic Diseases|June 20, 2017
Comparing polyarteritis nodosa in children and adults: a single center studyAbdulsamet Erden, Ezgi D Batu, Hafize E Sönmez, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO RegistryBayram Farisoğulları, Gözde Kübra Yardımcı, Alper Sarı, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registryEmre Bilgin, Bayram Farisoğulları, Berkan Armağan, et al.
Turkish Journal of Medical Sciences|September 27, 2020
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experienceEmre Bilgin, Furkan Ceylan, Emine Duran, et al.
Joint Bone Spine|November 24, 2022
Derivation and validation of adult Still Activity Score (SAS)Umut Kalyoncu, Timuçin Kasifoglu, Ahmet Omma, et al.
Clinical Rheumatology|January 28, 2022
Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry resultsGizem Ayan, Bayram Farisogulları, Emre Bilgin, et al.
Upsala Journal of Medical Sciences|January 25, 2018
Increased psoriasis frequency in patients with familial Mediterranean feverAbdulsamet Erden, Ezgi Deniz Batu, Emrah Seyhoğlu, et al.
Current Medical Research and Opinion|September 19, 2017
Poor outcomes among elderly patients hospitalized for influenza-like illnessMine Durusu Tanriover, Tülay Bagci Bosi, Lale Ozisik, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life dataUmut Kalyoncu, Emre Bilgin, Abdulsamet Erden, et al.
Pageof 10